Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 13.3B | 12.7B | 12.2B | 12.7B |
Cost of revenue | 8.3B | 7.6B | 7.3B | 7.9B |
Gross profit | 5.0B | 5.1B | 4.9B | 4.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 3.4B | 3.1B | 3.1B | 2.9B |
Operating income | 274.1M | 513.7M | 399.2M | 518.3M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 19.8M | 10.4M | 9.9M | 13.8M |
Other income expense | — | — | — | — |
Pretax income | 266.7M | 421.1M | 432.9M | 513.8M |
Tax provision | 78M | 110.2M | 118.8M | 138.4M |
Net income | 188.7M | 310.9M | 314.1M | 375.4M |
Basic EPS | — | 7.7 | 7.8 | 9.3 |
Diluted EPS | — | 7.7 | 7.8 | 9.3 |
Basic average shares | — | 40.5M | 40.5M | 40.5M |
Diluted average shares | — | 40.5M | 40.5M | 40.5M |
EBITDA | 623.6M | 809.1M | 748.1M | 826.3M |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |